News - Bristol Myers Squibb

Welcome to our newsroom. Here you will find all the latest news about Brystol Myers Squibb in the Netherlands. As a journalist, you will also find all press releases, contact details and visual material here.

Latest news

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis >

Bristol Myers Squibb today announced that the European Commission has approved Sotyktu (deucravacitinib), a first-in-class, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy, representing a new way of treating this chronic immune-mediated disease.

Koen van Elst (Stichting Melanoom) on World Cancer Day >

04-02-2023

"World Cancer Day has long taken place on February 4. Personally, I think it is important to reflect on this: recognition of a global disease that claims more and more victims every year. Cancer occurs in all stages of life: awareness can contribute to early recognition and the removal of a taboo."

Bristol Myers Squibb celebrates highest point of first European cell therapy production facility at Leiden Bio Science Park >

01-09-2022

The construction of the CAR T cell therapy production centre of Bristol Myers Squibb in the Leiden Bio Science Park (LBSP) is going fast. Today the highest point was reached which traditionally means a topping-off ceremony.

Read all recent news

Articles and press releases >

For all media inquiries

Ronald Jager

Senior Manager Corporate Affairs

Phone number: +31 30 300 22 22

E-mail: info.nl@bms.com

If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!